ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Nyxoah SA

Nyxoah SA (NYXH)

8,02
0,02
( 0,25% )
Aktualisiert: 09:19:31

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
8,02
Gebot
7,82
Fragen
7,98
Volumen
164
8,00 Tagesbereich 8,02
3,79 52-Wochen-Bereich 17,60
Marktkapitalisierung
Handelsende
8,00
Handelsbeginn
8,00
Letzte Trade
15
@
8.02
Letzter Handelszeitpunkt
09:07:29
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
14.231
Ausgegebene Aktien
28.674.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,32
Gewinn pro Aktie (EPS)
-1,51
Erlöse
4,35M
Nettogewinn
-43,21M

Über Nyxoah SA

Sektor
Health & Allied Services,nec
Branche
Health & Allied Services,nec
Website
Hauptsitz
Mont-saint-guibert, Walloon Brabant, Bel
Gegründet
-
Nyxoah SA is listed in the Health & Allied Services sector of the Euronext with ticker NYXH. The last closing price for Nyxoah was 8,00 €. Over the last year, Nyxoah shares have traded in a share price range of 3,79 € to 17,60 €.

Nyxoah currently has 28.674.000 shares in issue. The market capitalisation of Nyxoah is 229,39 € million. Nyxoah has a price to earnings ratio (PE ratio) of -5.32.

NYXH Neueste Nachrichten

Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference

Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgique – 20 Novembre 2024...

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November...

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH...

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 REGULATED INFORMATIONNovember 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext...

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

REGULATED INFORMATIONNovember 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”...

Invitation à assister à l'assemblée générale spéciale des actionnaires de la Société qui se tiendra le 19 décembre 2024

Invitation à assister à l'assemblée générale spéciale des actionnaires de la Société qui se tiendra le 19 décembre 2024 INFORMATIONS RÉGLEMENTÉESle 19 novembre 2024, 7:00h CET / 1:00h ET...

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence          INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 18 novembre...

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30...

Publication relating to transparency notifications

                 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14...

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating ResultsFDA approval on track for first quarter 2025, U.S. commercial team build out in progressCompany fully funded with...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.58-6.744186046518.68.67.66170988.0031346DE
4-1.06-11.67400881069.089.127.66128908.54540396DE
120.68.086253369277.429.786.66142318.3326182DE
26-1.4-14.86199575379.429.786.26208558.01443868DE
523.3872.84482758624.6417.63.79347919.10661933DE
156-11.38-58.659793814419.421.53.79162028.89146696DE
260-11.98-59.920303.791600911.83696112DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ATODSAtos SE
0,0051 €
(24,39%)
9,6M
ALMDPMedesis Pharma SA
0,51 €
(24,09%)
67,16k
SOISOITEC
71,90 €
(13,23%)
95,49k
ALINSIntrasense
0,314 €
(12,54%)
116,27k
ALVERVergnet
0,0053 €
(10,42%)
4,61M
EBUSEbusco Holding NV
0,818 €
(-33,28%)
278,72k
ALESEEntech SA
4,51 €
(-15,86%)
39,57k
VACBSPierre & Vacances
0,048 €
(-14,29%)
427
EMGDSEuromedis DS
0,0088 €
(-12,00%)
2,45k
ALVETTheraVet SA
0,0802 €
(-10,89%)
28,77k
ATODSAtos SE
0,0051 €
(24,39%)
9,6M
ALVERVergnet
0,0053 €
(10,42%)
4,61M
ATOAtos SE
0,1822 €
(-5,35%)
1,7M
BCPBanco Comercial Portugues SA
0,4407 €
(0,20%)
1,43M
ALCYBCybergun
0,0001 €
(0,00%)
1,32M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock